André Baruchel

20.6k total citations · 3 hit papers
333 papers, 9.7k citations indexed

About

André Baruchel is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, André Baruchel has authored 333 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Hematology, 171 papers in Public Health, Environmental and Occupational Health and 90 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in André Baruchel's work include Acute Lymphoblastic Leukemia research (165 papers), Acute Myeloid Leukemia Research (113 papers) and Childhood Cancer Survivors' Quality of Life (75 papers). André Baruchel is often cited by papers focused on Acute Lymphoblastic Leukemia research (165 papers), Acute Myeloid Leukemia Research (113 papers) and Childhood Cancer Survivors' Quality of Life (75 papers). André Baruchel collaborates with scholars based in France, Netherlands and Germany. André Baruchel's co-authors include Guy Leverger, Rob Pieters, Lewis B. Silverman, Martin Schrappe, Thierry Leblanc, Jacqueline Clavel, Brigitte Nelken, Stephen P. Hunger, Denis Hémon and Andrea Biondi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

André Baruchel

313 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

2015 592 citations Stephen P. Hunger, Rob Pieters et al. Journal of Clinical Oncology profile →
L‐asparaginase treatment in acute lymphoblastic leukemia

2010 445 citations Rob Pieters, Stephen P. Hunger et al. profile →
T cell malignancies after CAR T cell therapy in the DESCAR-T registry

2025 23 citations Nicolas Boissel, André Baruchel et al. profile →

Peers

Countries citing papers authored by André Baruchel

Since Specialization

Citations

This map shows the geographic impact of André Baruchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Baruchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Baruchel more than expected).

Fields of papers citing papers by André Baruchel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Baruchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Baruchel. The network helps show where André Baruchel may publish in the future.

Co-authorship network of co-authors of André Baruchel

This figure shows the co-authorship network connecting the top 25 collaborators of André Baruchel. A scholar is included among the top collaborators of André Baruchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Baruchel. André Baruchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic impact of the PredicT-ALL classifier in the AALL0434 trial: a model combining NGS, MRD, and WBC at diagnosis 2025 ·Blood Advances ·Mathieu Simonin, Nicolas Boissel, Arnaud Petit, Charles G. Mullighan, Stephen P. Hunger, Mignon L. Loh, Stuart C. Winter, Elizabeth Macintyre, David T. Teachey, André Baruchel, Vahid Asnafi	0
2	Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement 2025 ·HemaSphere ·Adam J. Lamble, Sandra D. Bohling, Kara L. Davis, Aimee C. Talleur, Kevin O. McNerney, (unknown), Priya Kumar, Rebecca Thomas, Hao‐Wei Wang, Constance M. Yuan, Elad Jacoby, André Baruchel, Sara Ghorashian, Michael A. Pulsipher, Liora M. Schultz, Rebecca Gardner, Nirali N. Shah	0
3	Monocentric experience of venetoclax‐based regimen in paediatric refractory and relapsed AML/MDS 2024 ·British Journal of Haematology ·(unknown), (unknown), Lauriane Goldwirt, Mathieu Simonin, (unknown), Marie-Émilie Dourthe, Marion Strullu, André Baruchel, Jean‐Hugues Dalle, Benoît Brethon	0
4	Educational outcomes in siblings of childhood leukemia survivors: Factors associated with school difficulties and comparison with general population 2024 ·Cancer Medicine ·(unknown), Pascal Auquier, Virginie Gandemer, Yves Bertrand, (unknown), (unknown), André Baruchel, (unknown), Jean‐Hugues Dalle, Pascal Chastagner, Justyna Kanold, Maryline Poirée, (unknown), (unknown), Isabelle Pellier, Gérard Michel, Julie Berbis	2
5	Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL) 2022 ·Journal of Clinical Medicine ·Jeannig Berrou, (unknown), (unknown), (unknown), (unknown), (unknown), Emmanuelle Clappier, Jean‐Michel Cayuela, André Baruchel, (unknown), Renaud Prudent, Jacques Ghysdael, Claude Gardin, Hervé Dombret, Thorsten Braun	4
6	Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop 2021 ·Blood Advances ·(unknown), Julien Calvo, (unknown), (unknown), (unknown), Sandrine Poglio, Thierry Leblanc, Arnaud Petit, André Baruchel, Paola Ballerini, Irina Naguibneva, Rima Haddad, Marie-Laure Arcangeli, Frédéric Mazurier, Françoise Pflumio, Benjamin Uzan	23
7	Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols 2021 ·Leukemia ·Mary Taj, Anthony V. Moorman, (unknown), Arnaud Petit, Vahid Asnafi, Fanny Alby‐Laurent, Ajay Vora, Marc R. Mansour, Rosemary E. Gale, Sylvie Chevret, John Moppett, André Baruchel, Elizabeth Macintyre	4
8	Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity 2021 ·Cancers ·(unknown), Odile Fenneteau, Guy Leverger, Arnaud Petit, André Baruchel, Françoise Méchinaud	14
9	Quality of life in parents of childhood leukemia survivors. A French Childhood Cancer Survivor Study for Leukemia study 2020 ·Pediatric Blood & Cancer ·Camille Vercasson, Pascal Auquier, Gérard Michel, Yves Bertrand, (unknown), (unknown), Guy Leverger, Virginie Gandemer, André Baruchel, Audrey Contet, (unknown), Catherine Paillard, Maryline Poirée, (unknown), Nicolas Sirvent, Justyna Kanold, Claire Freyçon, Zeinab Hamidou, Julie Berbis	12
10	Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia 2019 ·Blood Advances ·Marion Alcantara, Mathieu Simonin, Ludovic Lhermitte, Aurore Touzart, Marie-Émilie Dourthe, (unknown), Nathalie Grardel, Jean Michel Cayuela, Yves Chalandon, Carlos Graux, Hervé Dombret, Norbert Ifrah, Arnaud Petit, Elizabeth Macintyre, André Baruchel, Nicolas Boissel, Vahid Asnafi	14
11	Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation 2018 ·Biology of Blood and Marrow Transplantation ·Gerald V. Raymond, Patrick Aubourg, Asif Paker, Maria L. Escolar, Alain Fischer, Stéphane Blanche, André Baruchel, Jean‐Hugues Dalle, Gérard Michel, Vinod K. Prasad, Weston P. Miller, (unknown), (unknown), Joanne Kurtzberg, David Nascene, Paul J. Orchard, Troy C. Lund	82
12	Generic formulations of imatinib for treatment of Philadelphia chromosome–positive leukemia in pediatric patients 2018 ·Pediatric Blood & Cancer ·Meinolf Suttorp, Markus Metzler, Frédéric Millot, Hiroyuki Shimada, Deepak Bansal, Adalet Meral Güneş, Krzysztof Kałwak, Petr Sedláček, André Baruchel, Andrea Biondi, Nobuko Hijiya, Kirk R. Schultz, Martin Schrappe	10
13	Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia 2017 ·Blood ·Arnaud Petit, Amélie Trinquand, Sylvie Chevret, Paola Ballerini, Jean‐Michel Cayuela, Nathalie Grardel, Aurore Touzart, Benoît Brethon, Hélène Lapillonne, Claudine Schmitt, Sandrine Thouvenin, Gérard Michel, Claude Preudhomme, Jean Soulier, Judith Landman‐Parker, Guy Leverger, Elizabeth Macintyre, André Baruchel, Vahid Asnafi	61
14	MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML 2017 ·Oncogene ·(unknown), (unknown), Askar Obulkasim, Daria G. Valerio, Edwin Sonneveld, (unknown), Válerie de Haas, Dirk Reinhardt, M Zimmermann, Jan Trka, André Baruchel, Rob Pieters, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Maarten Fornerod	14
15	Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment 2015 ·Pediatric Pulmonology ·Lisa Giovannini‐Chami, (unknown), Alice Hadchouel, André Baruchel, Rachida Boukari, J.‐C. Dubus, Michaël Fayon, Muriel Le Bourgeois, Nadia Nathan, Marc Albertini, Annick Clément, J. de Blic	25
16	Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE Study 2014 ·Cancer Causes & Control ·Roula Ajrouche, Jérémie Rudant, Laurent Orsi, Arnaud Petit, André Baruchel, Brigitte Nelken, Marlène Pasquet, Gérard Michel, Christophe Bergeron, Stéphane Ducassou, Virginie Gandemer, Patrick Lutz, Laure Saumet, Xavier Rialland, Denis Hémon, Jacqueline Clavel	37
17	Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium 2013 ·Journal of Clinical Oncology ·C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud, (unknown), Thomas Lehrnbecher, Vincent H. J. van der Velden, Berna Beverloo, Monique L. den Boer, Rob Pieters, Dirk Reinhardt, Michael Dworzak, Julie Rosenberg, George Manos, Shruti Agrawal, Lewis C. Strauss, André Baruchel, Pamela Kearns	66
18	Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group 2012 ·Journal of Clinical Oncology ·Cécile Bally, Jehane Fadlallah, Guy Leverger, Yves Bertrand, Alain Robert, André Baruchel, Agnès Guerci, Christian Récher, Emmanuel Raffoux, Xavier Thomas, Thierry Leblanc, Nadia Idres, Bruno Cassinat, Norbert Vey, Christine Chomienne, Hervé Dombret, Miguel Á. Sanz, Pierre Fenaux, Lionel Adès	32
19	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia 2009 ·Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	80
20	A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin. 1992 ·Journal of Clinical Investigation ·Patrick G. Gallagher, William Tse, Thérèsa L. Coetzer, Marie‐Christine Lecomte, M Garbarz, Harold S. Zarkowsky, André Baruchel, Samir K. Ballas, D Dhermy, J Palek	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact